Renaissance Technologies’s Castle Biosciences CSTL Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $13.7M | Sell |
670,500
-30,700
| -4% | -$627K | 0.02% | 889 |
|
2025
Q1 | $14M | Buy |
701,200
+16,200
| +2% | +$324K | 0.02% | 832 |
|
2024
Q4 | $18.3M | Buy |
685,000
+195,438
| +40% | +$5.21M | 0.03% | 715 |
|
2024
Q3 | $14M | Buy |
489,562
+188,062
| +62% | +$5.36M | 0.02% | 870 |
|
2024
Q2 | $6.56M | Buy |
301,500
+96,800
| +47% | +$2.11M | 0.01% | 1140 |
|
2024
Q1 | $4.53M | Buy |
204,700
+92,300
| +82% | +$2.04M | 0.01% | 1480 |
|
2023
Q4 | $2.43M | Buy |
112,400
+5,600
| +5% | +$121K | ﹤0.01% | 1836 |
|
2023
Q3 | $1.8M | Sell |
106,800
-65,600
| -38% | -$1.11M | ﹤0.01% | 1931 |
|
2023
Q2 | $2.37M | Buy |
172,400
+136,000
| +374% | +$1.87M | ﹤0.01% | 1884 |
|
2023
Q1 | $827K | Buy |
36,400
+14,300
| +65% | +$325K | ﹤0.01% | 2598 |
|
2022
Q4 | $520K | Buy |
22,100
+5,100
| +30% | +$120K | ﹤0.01% | 2930 |
|
2022
Q3 | $443K | Sell |
17,000
-400
| -2% | -$10.4K | ﹤0.01% | 2997 |
|
2022
Q2 | $382K | Sell |
17,400
-7,600
| -30% | -$167K | ﹤0.01% | 3313 |
|
2022
Q1 | $1.12M | Sell |
25,000
-109,281
| -81% | -$4.9M | ﹤0.01% | 2662 |
|
2021
Q4 | $5.76M | Buy |
+134,281
| New | +$5.76M | 0.01% | 1437 |
|
2021
Q2 | – | Sell |
-27,500
| Closed | -$1.88M | – | 3503 |
|
2021
Q1 | $1.88M | Buy |
+27,500
| New | +$1.88M | ﹤0.01% | 2271 |
|
2020
Q4 | – | Sell |
-3,900
| Closed | -$201K | – | 3427 |
|
2020
Q3 | $201K | Sell |
3,900
-38,936
| -91% | -$2.01M | ﹤0.01% | 3109 |
|
2020
Q2 | $1.61M | Buy |
42,836
+9,636
| +29% | +$363K | ﹤0.01% | 2296 |
|
2020
Q1 | $990K | Buy |
+33,200
| New | +$990K | ﹤0.01% | 2430 |
|